ROSEN, A RESPECTED LAW FIRM, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors With Losses to Secure Counsel Before Important February 28 Deadline in Securities Class Action – INSD, MZKR
February 19, 2022 07:18 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 19, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTC: INSD,...
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – INSD, MZKR
February 11, 2022 15:18 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTC: INSD,...
Deadline on Feb. 28th in Lawsuit for Investors with over $150,000 in Instadose Pharma Corp. (OTC: INSD) shares announced by Shareholders Foundation
January 27, 2022 10:25 ET
|
Shareholders Foundation, Inc.
SAN DIEGO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced that a deadline is coming up on February 28th in the lawsuit that was filed for certain investors in shares...
ROSEN, A TOP RANKED LAW FIRM, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors With Losses to Secure Counsel Before Important February 28 Deadline in Securities Class Action – INSD, MZKR
January 16, 2022 11:45 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 16, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (OTCMKTS:...
INSD SHAREHOLDER ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Instadose Pharma Corp. Investors with Losses to Inquire About Class Action Investigation – INSD
December 07, 2021 14:45 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 07, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Instadose...